Skip to Content

Tag: CPAP Therapy


Vendors

sovaSage's Jeanie grants ‘strategic advantage’ 

June 2, 2023Liz Beaulieu, Editor

PITTSBURGH – sovaSage is in a “huge growth cycle,” with a new product for patients on CPAP therapy called TherapistAssist Jeanie and a number of key hires, says William Kaigler, co-founder.  The company had a soft launch for Jeanie, an artificial intelligence-based virtual coach that delivers customized written and video-based content to patients 24/7/365, at Medtrade in March.  “There’s nothing else like it,” said Kaigler, who previously founded...

CPAP Therapy, sovaSage, TherapistAssist Jeanie


Read Full Articlered right arrow icon

Also Noted

Sleep Solutions patients see benefit of V-Com 

March 31, 2023HME News Staff

DETROIT – Sleep Solutions, an HME provider based here, recently completed a trial of 100 patients starting CPAP therapy, with 50 patients receiving standard care and 50 patients receiving standard care with the V-Com device. The provider found 12% more of those using V-Com group met the 90-day CMS requirement for adherence. “Most importantly, this is wonderful for the health of our patients,” said Robyn Parrot, president of Sleep Solutions. “But these results also improve...

Adherence, CPAP Therapy, sleep solutions, V-Com


Read Full Articlered right arrow icon

Also Noted

Study finds statins, but not CPAP therapy, can reduce heart disease

March 22, 2023HME News Staff

NEW YORK – A new study from Columbia University researchers suggests that cholesterol-lowering drugs called statins can potentially reduce heart disease in people with obstructive sleep apnea. But, while CPAP therapy improves sleep quality and reduces daytime fatigue in people with OSA, findings from several recent clinical trials show it does not improve heart health as physicians originally hoped, according to a press release by Columbia University Irving Medical Center. “Alternative...

CPAP Therapy, Heart disease, statins


Read Full Articlered right arrow icon

Also Noted

Sleeplay expands foothold 

March 6, 2023HME News Staff

MIAMI – Sleeplay, an online sleep provider, has launched a mobile application. The app, available on the App Store and Google Play Store, will give customers access to online CPAP experts, user-friendly upload Rx for fast order placement and visibility into past orders, the company says. “We’re thrilled to announce the launch of the Sleeplay app and expand our foothold in the CPAP and luxury sleep space,” said Aaron Fuhrman, founder and director of Sleeplay. “Adapting...

CPAP Therapy, Mobile app, Online, Provider, Sleeplay


Read Full Articlered right arrow icon

Also Noted

React Health partners with SleepRes 

February 13, 2023HME News Staff

SARASOTA, Fla. – React Health has a new distribution agreement with SleepRes to provide V-Com with new CPAP orders in the United States. V-Com is placed between the CPAP mask and hose to reduce inspiratory pressure and flow, providing comfort with minimal to no reduction in expiratory pressure (EPAP). “React Health is committed to providing innovative options to improve comfort and patient tolerance to PAP therapy,” said Clint Geffert, president, commercial operations, Reach Health....

CPAP Therapy, React Health, SleepRes, V-Com


Read Full Articlered right arrow icon

Also Noted

AASM launches ‘More than a Snore’ 

February 7, 2023HME News Staff

DARIEN, Ill. - The American Academy of Sleep Medicine has launched a new national campaign called “More than a Snore” to raise awareness of obstructive sleep apnea. “This campaign will raise national awareness of obstructive sleep apnea and encourage undiagnosed patients to advocate for themselves and seek treatment,” said Jennifer Martin, a licensed clinical psychologist and president of the AASM. “It is important that patients and health care professionals feel confident...

American Academy of Sleep Medicine (AASM), CPAP Therapy, Sleep Apnea


Read Full Articlered right arrow icon

Vendors

ResMed reports ‘strong sales growth’ 

January 26, 2023HME News Staff

SAN DIEGO – ResMed reported revenue increased by 16% to $1.03 billion in the second quarter of fiscal year 2023 compared to the same period the previous year.  Net income was $224.9 million vs. $216.2 million.  “During the second quarter, we significantly increased production and delivery of flow generator devices to meet the incredible demand from customers, resulting in strong sales growth in the Americas, and solid overall performance for our business across 140 countries,”...

CPAP Therapy, ResMed


Read Full Articlered right arrow icon

Also Noted

NasoClenz has potential to increase CPAP compliance, study finds 

November 8, 2022HME News Staff

FRISCO, Texas – NasoClenz reduced bacterial colonization, while increasing comfort and compliance, in patients who use CPAP therapy to treat sleep apnea, according to the results of a clinical evaluation recently presented at the American College of Surgeons Clinical Congress. “Sleep apnea is a very serious health issue,” said lead author and presenter Keith Matheny, MD, FARS. “Anything we can offer patients that might help improve compliance with CPAP will have a tremendous...

CPAP Compliance, CPAP Therapy, NasoClenz


Read Full Articlered right arrow icon

News

In brief: Sleep rebound, Philips settlement, Invacare noncompliance 

September 30, 2022HME News Staff

NEW YORK – HME providers saw a 6.3% decline in their sleep patient volume in the last 12 months, but they expect double-digit growth in the next 12 months, according to the third quarter HME Sleep and Oxygen Survey from Needham.  The decline in sleep is mainly due to a shortage in flow generators. The eventual re-entry of Philips into the flow generator market appears likely to come mostly at the expense of smaller competitors rather than ResMed, according to the survey.  Respondents...

CPAP Therapy, Invacare, Philips, Settlement, Stock


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed aims to ‘lock in’ increasing market share

August 12, 2022Liz Beaulieu, Editor

SAN DIEGO – Mick Farrell’s tone has shifted slightly when it comes to ResMed increasing its market share amid a major competitor’s recall.  During a conference call to discuss the company’s fourth quarter and fiscal year 2022 financial results, the CEO said he no longer looks at it as “incremental or temporal.”  “This is permanent share taking,” he said. “We’re going to go in, we’re going to get share and we’re...

CPAP Recall, CPAP Therapy, Mick Farrell, ResMed


Read Full Articlered right arrow icon